We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$89.3B
AUM Growth
+$8.23B
Cap. Flow
+$1.9B
Cap. Flow %
2.12%
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,236
Closed
38

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$60.1M
2
TSM icon
TSMC
TSM
+$59.1M
3
TSLA icon
Tesla
TSLA
+$56M
4
AAPL icon
Apple
AAPL
+$55.2M
5
AMZN icon
Amazon
AMZN
+$47.5M

Top Sells

Rank Stock Value
1
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$102M
2
EG icon
Everest Group
EG
+$27.4M
3
CVX icon
Chevron
CVX
+$25M
4
WFC icon
Wells Fargo
WFC
+$24.9M
5
CXT icon
Crane NXT
CXT
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 27.27%
2 Healthcare 12.98%
3 Financials 12.17%
4 Consumer Discretionary 11.18%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LII icon
426
Lennox International
LII
$15.4B
$33.1M 0.04%
101,530
+2,351
+2% +$664K
WTRG icon
427
Essential Utilities
WTRG
$11.2B
$33.1M 0.04%
829,449
+135,928
+20% +$5.7M
TSN icon
428
Tyson Foods
TSN
$20.7B
$33.1M 0.04%
648,532
+1,613
+0.2% +$87.8K
ARMK icon
429
Aramark
ARMK
$14.8B
$32.9M 0.04%
1,058,220
+26,790
+3% +$730K
JBHT icon
430
JB Hunt Transport Services
JBHT
$25.8B
$32.8M 0.04%
181,144
-4,933
-3% -$858K
EXPE icon
431
Expedia Group
EXPE
$37.5B
$32.6M 0.04%
297,596
-6,279
-2% -$615K
SWAV
432
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$32.4M 0.04%
113,484
+16
+0% +$4.44K
PAYC icon
433
Paycom
PAYC
$8.17B
$32.1M 0.04%
99,966
+2,784
+3% +$821K
ESS icon
434
Essex Property Trust
ESS
$18.5B
$32M 0.04%
136,683
+3,664
+3% +$801K
HZNP
435
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$32M 0.04%
311,132
+37,657
+14% +$3.97M
RRX icon
436
Regal Rexnord
RRX
$14.6B
$31.3M 0.04%
203,554
+2,172
+1% +$296K
CBOE icon
437
Cboe Global Markets
CBOE
$30.1B
$31.2M 0.04%
226,265
+10,472
+5% +$1.43M
UTHR icon
438
United Therapeutics
UTHR
$22B
$31.1M 0.03%
140,779
+6,997
+5% +$1.55M
CCK icon
439
Crown Holdings
CCK
$13.2B
$31M 0.03%
357,067
+206,718
+137% +$17M
NBIX icon
440
Neurocrine Biosciences
NBIX
$16.9B
$31M 0.03%
328,307
+21,713
+7% +$2.12M
CAG icon
441
Conagra Brands
CAG
$7.18B
$30.8M 0.03%
913,100
-258
-0% -$9.31K
HBAN icon
442
Huntington Bancshares
HBAN
$35.5B
$30.8M 0.03%
2,853,012
+80,347
+3% +$859K
POOL icon
443
Pool Corp
POOL
$7.39B
$30.6M 0.03%
81,638
-1,267
-2% -$433K
USFD icon
444
US Foods
USFD
$21.8B
$30.5M 0.03%
694,313
+74,403
+12% +$2.95M
DAR icon
445
Darling Ingredients
DAR
$9.56B
$30.5M 0.03%
477,726
+6,472
+1% +$394K
CASY icon
446
Casey's General Stores
CASY
$31.5B
$30.5M 0.03%
124,905
+7,071
+6% +$1.6M
TEAM icon
447
Atlassian
TEAM
$28B
$30.5M 0.03%
181,520
+23,271
+15% +$3.73M
JKHY icon
448
Jack Henry & Associates
JKHY
$11.1B
$30.5M 0.03%
181,987
-2,712
-1% -$422K
PKG icon
449
Packaging Corp of America
PKG
$22.8B
$30.3M 0.03%
229,252
-1,309
-0.6% -$175K
LAMR icon
450
Lamar Advertising Co
LAMR
$16.1B
$30.3M 0.03%
305,089
+8,561
+3% +$831K

Similar funds

RhumbLine Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,236 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
  • RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
  • RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
  • RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
  • RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.

Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.